‘The Gruber Moment’: How CBER Got The Answers It Wanted On COVID Vaccine Guidance

US FDA's CBER's Office of Vaccine Research & Review Director Marion Gruber presents during the 22 October VRBPAC meeting.
CBER's Office of Vaccine Research & Review Director Marion Gruber presents during the 22 October VRBPAC meeting. • Source: Screenshot
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from US FDA Performance Tracker

More from Regulatory Trackers